Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · IEX Real-Time Price · USD
86.85
-2.05 (-2.31%)
Apr 19, 2024, 4:00 PM EDT - Market closed

Blueprint Medicines Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for Blueprint Medicines stock have an average target of 83.86, with a low estimate of 43 and a high estimate of 115. The average target predicts a decrease of -3.44% from the current stock price of 86.85.

Analyst Consensus: Buy
Target Low Average Median High
Price $43 $83.86 $85 $115
Change -50.49% -3.44% -2.13% +32.41%

Analyst Ratings

The average analyst rating for BPMC stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Nov '23Dec '23Jan '24Feb '24Mar '24Apr '24
Strong Buy 656666
Buy 444444
Hold 333332
Sell 111111
Strong Sell 000111
Total 141314151514

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JMP Securities
JMP Securities
Buy
Reiterates
$114
Buy Reiterates $114 +31.26% Apr 10, 2024
Needham
Needham
Strong Buy
Reiterates
$97
Strong Buy Reiterates $97 +11.69% Feb 26, 2024
JMP Securities
JMP Securities
Buy
Reiterates
$114
Buy Reiterates $114 +31.26% Feb 16, 2024
Citigroup
Citigroup
Strong Sell
Maintains
$54$65
Strong Sell Maintains $54$65 -25.16% Feb 16, 2024
Barclays
Barclays
Hold
Maintains
$58$70
Hold Maintains $58$70 -19.40% Feb 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
400.57M
from 249.38M
Increased by 60.63%
Revenue Next Year
607.95M
from 400.57M
Increased by 51.77%
EPS This Year
-5.66
from -8.37
EPS Next Year
-2.83
from -5.66
Year 2019202020212022202320242025202620272028
Revenue
66.51M793.74M180.08M204.04M249.38M400.57M607.95M845.96M968.98M1.04B
Revenue Growth
49.39%1,093.37%-77.31%13.30%22.22%60.63%51.77%39.15%14.54%7.33%
EPS
-7.275.59-11.01-9.35-8.37-5.66-2.830.572.312.57
EPS Growth
--------305.36%11.22%
No. Analysts -----191915106
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 471.5M 775.9M 1.1B 1.3B 1.2B
Avg 400.6M 608.0M 846.0M 969.0M 1.0B
Low 364.6M 471.6M 600.1M 670.7M 799.8M

Revenue Growth

Revenue Growth 20242025202620272028
High
89.0%
93.7%
77.0%
55.9%
27.5%
Avg
60.6%
51.8%
39.1%
14.5%
7.3%
Low
46.2%
17.7%
-1.3%
-20.7%
-17.5%

EPS Forecast

EPS 20242025202620272028
High -4.59 -0.28 4.54 8.36 4.56
Avg -5.66 -2.83 0.57 2.31 2.57
Low -6.15 -6.33 -2.41 -2.48 -0.31

EPS Growth

EPS Growth 20242025202620272028
High - - -
1,369.0%
97.6%
Avg - - -
305.4%
11.2%
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.